000 01415 a2200337 4500
005 20250515180239.0
264 0 _c20091014
008 200910s 0 0 eng d
022 _a1747-3667
024 7 _a10.1097/01.hjh.0000357907.68402.99
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFerrari, Roberto
245 0 0 _aCardiovascular protection: a breakthrough for high-risk patients?
_h[electronic resource]
260 _bJournal of hypertension. Supplement : official journal of the International Society of Hypertension
_cJul 2009
300 _aS37-40 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAngiotensin II Type 1 Receptor Blockers
_xpharmacology
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xpharmacology
650 0 4 _aBenzimidazoles
_xpharmacology
650 0 4 _aBenzoates
_xpharmacology
650 0 4 _aCardiovascular Diseases
_xepidemiology
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aHypertension
_xcomplications
650 0 4 _aRamipril
_xpharmacology
650 0 4 _aRenin-Angiotensin System
_xdrug effects
650 0 4 _aRisk Factors
650 0 4 _aTelmisartan
773 0 _tJournal of hypertension. Supplement : official journal of the International Society of Hypertension
_gvol. 27
_gno. 5
_gp. S37-40
856 4 0 _uhttps://doi.org/10.1097/01.hjh.0000357907.68402.99
_zAvailable from publisher's website
999 _c19002588
_d19002588